BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

181 hedge funds and large institutions have $2.84B invested in Blueprint Medicines in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+6
Holders Change %
+3.43%
% of All Funds
4.15%
Holding in Top 10
7
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-41.67%
% of All Funds
0.16%
New
36
Increased
74
Reduced
45
Closed
30
Calls
$37.1M
Puts
$21.4M
Net Calls
+$15.7M
Net Calls Change
+$15.5M

Top Buyers

1
Fidelity International
1
Fidelity International
Bermuda
$47.2M
2
State Street
2
State Street
Massachusetts
$117M
3
CC
3
Casdin Capital
New York
$40.3M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$22.1M
5
Deutsche Bank
5
Deutsche Bank
Germany
$26M

Top Sellers

1
TGI
1
TRV GP II
Massachusetts
$55.8M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$52.4M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
BC
4
Boxer Capital
California
$0
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$198M
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
$26M +$16.2M +255,150 +166%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$25.9M +$1.99M +31,415 +8%
Morgan Stanley
28
Morgan Stanley
New York
$23.7M +$11.8M +186,125 +99%
Goldman Sachs
29
Goldman Sachs
New York
$22.5M +$5.1M +80,265 +29%
OM
30
Opaleye Management
Massachusetts
$22.2M -$15.9M -250,000 -42%
Two Sigma Investments
31
Two Sigma Investments
New York
$22.1M +$17.3M +272,350 +361%
FCMI
32
Foresite Capital Management III
California
$15.9M -$9.52M -150,000 -38%
Renaissance Technologies
33
Renaissance Technologies
New York
$15.6M +$15.6M +245,800 New
Alkeon Capital Management
34
Alkeon Capital Management
New York
$15.6M +$8.47M +133,500 +120%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$14.4M +$9.64M +151,800 +202%
Jennison Associates
36
Jennison Associates
New York
$14M +$788K +12,408 +6%
Westfield Capital Management
37
Westfield Capital Management
Massachusetts
$13.5M +$13.5M +212,980 New
Charles Schwab
38
Charles Schwab
California
$13.2M +$637K +10,042 +5%
RSCM
39
Rock Springs Capital Management
Maryland
$12.6M +$2.62M +41,247 +26%
Citigroup
40
Citigroup
New York
$12.3M +$12.2M +192,478 +30,747%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$12.2M -$799K -12,591 -6%
TA
42
Teachers Advisors
New York
$11.3M +$112K +1,758 +1%
EAM
43
Eventide Asset Management
Massachusetts
$9.52M – – –
TCM
44
Tekla Capital Management
Massachusetts
$9.27M +$4.56M +71,780 +97%
DCM
45
Driehaus Capital Management
Illinois
$8.77M -$10M -158,196 -53%
EAM
46
Eagle Asset Management
Florida
$8.56M +$8.56M +134,842 New
UBS AM
47
UBS AM
Illinois
$8.05M +$1.2M +18,876 +17%
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$7.6M +$2.89M +45,602 +61%
TCIM
49
TIAA CREF Investment Management
New York
$6.72M -$588K -9,269 -8%
Bank of America
50
Bank of America
North Carolina
$6.49M +$4.59M +72,250 +241%
1
2
3 4 5